This translation has been automatically generated and has not been verified for accuracy.A person grabs a syringe from a cooler at a COVID-19 vaccine drive-thru clinic at Richardson Stadium in Kingston, Ont., on May 28, 2021. Calgary-based Providence Therapeutics says it has signed two contracts to have its developmental mRNA vaccine made in Canada.
A Phase 2 clinical trial in 525 people is now about to begin to further test the safety and effectiveness of the vaccine. Canada’s lacklustre manufacturing capacity for vaccines was a major issue heading into the COVID-19 vaccination procurement process and the federal government is working to expand the industry.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: